International Price Discrimination: The Pharmaceutical Industry
January 1986
Article
volume 14, issue 9 pp 1141-1150.
This publication is part of collection
| Related Files |
|---|
View PDF Version
(Int Price Discrimination.pdf, 0.9MB) |
It is generally asserted that price discrimination is a common feature of the international pharmaceutical market, resulting in unnecessarily high medical costs to developing countries, since it is pharmaceuticals that are the largest component of their health care expenditures. However, little comprehensive empirical research has been carried out to test this hypothesis.
Keywords
